Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
暂无分享,去创建一个
R. Steinman | M. Colonna | A. Salazar | J. Idoyaga | M. P. Longhi | M. Caskey | C. Trumpfheller | I. Matos | Courtney Kluger | M. Longhi
[1] R. Steinman,et al. Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques , 2009, PLoS pathogens.
[2] Shizuo Akira,et al. The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.
[3] R. Steinman,et al. CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells1 , 2008, The Journal of Immunology.
[4] F. Sallusto,et al. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation , 2008, European journal of immunology.
[5] C. Alonso,et al. Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice. , 2008, Microbes and infection.
[6] D. Monack. Faculty Opinions recommendation of Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. , 2008 .
[7] F. Re,et al. Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP31 , 2008, The Journal of Immunology.
[8] Henk C. Hoogsteden,et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells , 2008, The Journal of experimental medicine.
[9] R. Steinman,et al. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine , 2008, Proceedings of the National Academy of Sciences.
[10] G. Randolph,et al. Antigen presentation by monocytes and monocyte-derived cells. , 2008, Current opinion in immunology.
[11] 熊谷 雄太郎,et al. Alveolar macrophages are the primary interferon-α producer in pulmonary infection with RNA viruses , 2008 .
[12] M. Colonna,et al. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells , 2007, The Journal of experimental medicine.
[13] B. Pulendran,et al. The science of adjuvants , 2007, Expert review of vaccines.
[14] J. Farrar,et al. IFN-α Is Not Sufficient to Drive Th1 Development Due to Lack of Stable T-bet Expression1 , 2007, The Journal of Immunology.
[15] S. Akira,et al. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. , 2007, Immunity.
[16] Thomas C. Mitchell,et al. The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 , 2007, Science.
[17] M. Nolte,et al. Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo , 2007, The Journal of experimental medicine.
[18] L. Vitale,et al. Antigenic Targeting of the Human Mannose Receptor Induces Tumor Immunity1 , 2007, The Journal of Immunology.
[19] S. Akira,et al. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. , 2007, International immunology.
[20] D. Gabrilovich,et al. Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands. , 2007, Blood.
[21] R. Steinman,et al. Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.
[22] L. Moldawer,et al. Maturation of murine bone marrow-derived dendritic cells with poly(I:C) produces altered TLR-9 expression and response to CpG DNA. , 2006, Immunology letters.
[23] Rino Rappuoli,et al. Vaccine manufacturing: challenges and solutions , 2006, Nature Biotechnology.
[24] T. Heng,et al. De novo production of antigen-specific suppressor cells in vivo , 2006, Nature Protocols.
[25] W. Gillanders,et al. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu. , 2006, Vaccine.
[26] A. Ashkar,et al. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. , 2006, Cellular immunology.
[27] Richard A Flavell,et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[28] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[29] D. Tough,et al. Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming1 , 2006, The Journal of Immunology.
[30] C. Havenar-Daughton,et al. Cutting Edge: The Direct Action of Type I IFN on CD4 T Cells Is Critical for Sustaining Clonal Expansion in Response to a Viral but Not a Bacterial Infection1 , 2006, The Journal of Immunology.
[31] Bali Pulendran,et al. Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development , 2006, Cell.
[32] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[33] Bruce S. Thompson,et al. The low‐toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells , 2005, Journal of leukocyte biology.
[34] K. Takeda. [Toll-like receptor]. , 2005, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.
[35] L. Zitvogel,et al. Natural-killer cells and dendritic cells: "l'union fait la force". , 2005, Blood.
[36] J. Sprent,et al. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.
[37] L. Moretta,et al. NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor , 2005 .
[38] Francesco Bertoni,et al. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells , 2005, Nature Immunology.
[39] Osamu Takeuchi,et al. Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.
[40] S. Durham,et al. Monophosphoryl lipid A (MPL®) * promotes allergen‐induced immune deviation in favour of Th1 responses , 2005, Allergy.
[41] G. Trinchieri,et al. Type I interferon dependence of plasmacytoid dendritic cell activation and migration , 2005, The Journal of experimental medicine.
[42] C. Sousa,et al. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function , 2005, Nature Immunology.
[43] S Gordon,et al. Macrophage receptors and immune recognition. , 2005, Annual review of immunology.
[44] R. Flavell,et al. TLR-Independent Induction of Dendritic Cell Maturation and Adaptive Immunity by Negative-Strand RNA Viruses1 , 2004, The Journal of Immunology.
[45] Antonio Lanzavecchia,et al. Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming , 2004, Nature Immunology.
[46] J. Farrar,et al. Frontline: Absence of functional STAT4 activation despite detectable tyrosine phosphorylation induced by murine IFN‐α , 2004, European journal of immunology.
[47] A. Mazzoni,et al. Controlling the Toll road to dendritic cell polarization , 2004, Journal of leukocyte biology.
[48] P. Borrow,et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon , 2003, Nature Immunology.
[49] S. Akira,et al. Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] R. Steinman,et al. Activation of Natural Killer T Cells by -Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein , 2003 .
[51] R. Koup,et al. Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses , 2003 .
[52] J. Mascola,et al. 2 – IMMUNOLOGY: PART A. Basic Immunology of Vaccine Development , 2003 .
[53] I. Weissman,et al. Langerhans cells renew in the skin throughout life under steady-state conditions , 2003, Nature Immunology.
[54] Michel C. Nussenzweig,et al. Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance , 2002, The Journal of experimental medicine.
[55] I. Weissman,et al. Langerhans cells renew in the skin throughout life under steady-state conditions , 2002, Nature Immunology.
[56] Ion Gresser,et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. , 2002, Blood.
[57] E. Raz,et al. Cross-Priming of CD8 + T Cells by Immunostimulatory Sequence DNA , 2002 .
[58] Jianfei Yang,et al. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells , 2002, Nature Immunology.
[59] A. Sher,et al. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[60] Virginia Pascual,et al. Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.
[61] T. Di Pucchio,et al. Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. , 2001, Blood.
[62] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[63] Michel C. Nussenzweig,et al. Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.
[64] J. Webb,et al. Cytokine expression by murine DX5+ cells in response to IL-12, IL-18, or the combination of IL-12 and IL-18. , 2001, Cellular immunology.
[65] M. Kurimoto,et al. IFN‐α and IL‐18 synergistically enhance IFN‐γ production in human NK cells: differential regulation of Stat4 activation and IFN‐γ gene expression by IFN‐α and IL‐12 , 2001 .
[66] F. Belardelli,et al. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.
[67] G. Melioli,et al. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. , 2001, Immunology letters.
[68] T. Di Pucchio,et al. Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice , 2000, The Journal of experimental medicine.
[69] I. Weissman,et al. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[70] Stefania Gallucci,et al. Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.
[71] R. Verdijk,et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. , 1999, Journal of immunology.
[72] N. Lycke,et al. Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses. , 1999, Journal of immunology.
[73] M. Caligiuri,et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. , 1999, Journal of immunology.
[74] P. Marrack,et al. Type I Interferons Keep Activated T Cells Alive , 1999, The Journal of experimental medicine.
[75] R. Zinkernagel,et al. IL-12 is not required for induction of type 1 cytokine responses in viral infections. , 1999, Journal of immunology.
[76] S. Akira,et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. , 1998, Journal of immunology.
[77] A. N. Park,et al. Interferon‐α and granulocyte‐macrophage colony‐stimulating factor differentiate peripheral blood monocytes into potent antigen‐presenting cells , 1998, Journal of leukocyte biology.
[78] K. Pang,et al. Type I IFNs enhance the terminal differentiation of dendritic cells. , 1998, Journal of immunology.
[79] B. Haagmans,et al. Mice lacking IL-12 develop polarized Th1 cells during viral infection. , 1998, Journal of immunology.
[80] J. de Maeyer-Guignard,et al. Type I interferons. , 1998, International reviews of immunology.
[81] I. Orme,et al. Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.
[82] M. Biffi,et al. Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells , 1997, The Journal of experimental medicine.
[83] J. Sprent,et al. Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo , 1996, Science.
[84] D. Carvajal,et al. IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .
[85] K. Murphy,et al. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. , 1996, Journal of immunology.
[86] H. Okamura,et al. Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.
[87] G. Trinchieri,et al. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. , 1994, Blood.
[88] P. Musiani,et al. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells. , 1994, Journal of immunology.
[89] A. Sher,et al. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. , 1994, Journal of immunology.
[90] B. Devulder. L'union fait la force… , 1994 .
[91] C. Heusser,et al. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells , 1993, The Journal of experimental medicine.
[92] V. Devita,et al. A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. , 1976, Journal of the National Cancer Institute.
[93] T. Kobayasi. [The Langerhans cells]. , 1975, Ugeskrift for laeger.
[94] D. Burke,et al. Studies on the production, mode of action and properties of interferon. , 1957, British journal of experimental pathology.
[95] Y NAGANO,et al. [Immunizing property of vaccinia virus inactivated by ultraviolets rays]. , 1954, Comptes rendus des seances de la Societe de biologie et de ses filiales.